The United States will begin participating in an international collaboration to distribute COVID-19 vaccines more equitably around the world after President Joe Biden reversed the Trump administration’s withdrawal from the World Health Organization on his first day in office. Richard Marlink, the director of Rutgers Global Health Institute, discusses the impact COVAX, the global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, will have on ending the COVID-19 pandemic and strengthening global health. To read the full story.
Recent Posts
- Are synthetic food dyes unsafe? Experts reveal what the research really shows.
- How Much Should Doctors Dwell On Risks?
- NJACTS Community Engagement Core COVID-19 Resources
- Lawsuits Could Choke Off the Candy‑Flavored Vape Pipeline.
- Knowing Your Alzheimer’s Risk May Ease Anxiety but Reduce Motivation for Healthy Habits.
Categories
- Community (2,282)
- Covid (987)
- CTO Events (6)
- News (2,905)
- Pilots (21)